Sugar Maple Asset Management »

SPDR S&P Biotech shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $285k 1.8k 157.68

More positions owned by Sugar Maple Asset Management

Ishares Tr TRS FLT RT BD (TFLO)
Abbvie (ABBV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Abbott Laboratories (ABT)
Ishares Silver Tr Ishares (SLV)
Vaneck Etf Trust Clo Etf (CLOI)
Ea Series Trust Sarma Thema Etf (LENS)
Bny Mellon Etf Trust Ii Dynamic Value (BKDV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Palo Alto Networks (PANW)
Ishares Tr Msci Usa Min Etf (USMV)
Harris Oakmark Etf Trust Oakmark U S Lrg (OAKM)

View all positions for Sugar Maple Asset Management

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Bank of America Corporation
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Citadel Advisors
Wells Fargo & Company
UBS Group
Peak6
Barclays
Millennium Management
Leucadia National Corporation
Jpmorgan Chase & Co
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech